Baxter Sigma Spectrum Infusion Pump Recall: Alarm Failure Linked To At Least Three Deaths

An alarm may fail to warn of an upstream occlusion indicating the flow of drugs or fluids is blocked.

More than a quarter million Baxter Sigma Spectrum infusion pumps are being recalled after at least three patients died due to an alarm failure.

The FDA announced the Sigma Spectrum Infusion Pump recall on March 11, giving it a class I designation; meaning the agency feels the problems with the infusion pump are likely to cause significant injuries or deaths. Baxter Healthcare, the manufacturer, has already reported it has received 51 reports of serious injuries and three patient deaths over the last five years due to problems with the recalled infusion pumps.

The recalled devices are software-controlled infusion pumps which deliver fluid drugs or blood products directly into patients’ veins while they are in the hospital or another healthcare facility. However, according to Baxter, the devices can fail to issue an alarm for repeated upstream occlusion event, which occurs when the flow of fluids is blocked.

Learn More About

Medtronic MiniMed Lawsuits

Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries.


If the occlusion event is not resolved, the alarm will not sound again for the remainder of that infusion. The device may appear to be functioning normally, but may be infusing below the programmed rate or not at all, meaning patients are not getting their full dosage and may not be receiving crucial medical care.

The recall affects Baxter Sigma Spectrum Infusion Pumps with Master Drug Library (Version 8) with product code 35700BAX2, and Spectrum IQ Infusion Systems with Dose IQ Safety Software (Version 9) with product code 3570009. The recalled devices were distributed from February 5, 2015 to present.

The recall affects an estimated 277,450 devices sold throughout the United States.

Baxter first warned its customers of the problem in an Urgent Safety Communication in late December, according to the FDA, urging clinicians to be aware of the problem and giving them specific instructions on how to watch for it, and what to do if the situation occurs.

Customers with questions are asked to contact their Baxter Sales Representative, or Baxter Technical Assistance at 800-356-3454.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AT&T Data Breach Class Action Claims Telecom Giant
AT&T Data Breach Class Action Claims Telecom Giant "Disregarded" Customer Financial Safety (Posted today)

A Missouri woman is one of the latest person to file an class action claim over the AT&T data breach, after the telecom company admitted that hackers stole millions of customers' personal information and sold it on the internet.

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted yesterday)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.